LETTER TO THE JOURNAL
Dual inhibition of sirtuins 1 and 2: reprogramming metabolic energy dynamics in chronic myeloid leukemia as an immunogenic anticancer strategy
Michael Schnekenburger, Anne Lorant, Sruthi Reddy Gajulapalli, Ridhika Rajora, Jin-Young Lee, Aloran Mazumder, Haeun Yang, Christo Christov, Hyoung Jin Kang, Bernard Pirotte, Marc Diederich
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 7/8/2024 doi:10.1002/cac2.12590
LETTER TO THE JOURNAL
SALIRI-based (raltitrexed plus irinotecan) therapy as a second-line treatment for patients with metastatic colorectal cancer (SALLY): A prospective, multicenter, non-interventional, registry study
Shuqui Qin, Jin Li, Aiping Zhou, Yanqiao Zhang, Xianglin Yuan, Liangjun Zhu, Baoli Qin, Shan Zeng, Lin Shen, Ying Yuan, Weibo Wang, Jun Liang, Xianwen Zhang, Feng Ye, Ping Chen, Huaizhang Wang, Zhenyan Yu, Lu Yue, Yong Fang, Jianping Xiong, Jianwei Yang,
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 7/8/2024 doi:10.1002/cac2.12586
Editorial
Boron neutron capture therapy of cancer: where do we stand now?
Boron neutron capture therapy of cancer: where do we stand now?
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 7/8/2024 doi:10.1002/cac2.12581
LETTER TO THE JOURNAL
Oral transforming growth factor-beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity
Sung Hee Choi, Jay Thomas Myers, Suzanne Louise Tomchuck, Melissa Bonner, Saada Eid, Daniel Tyler Kingsley, Kristen Ashley VanHeyst, Seong-Jin Kim, Byung-Gyu Kim, Alex Yee-Chen Huang
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 7/6/2024 doi:10.1002/cac2.12589
LETTER TO THE JOURNAL
Fusobacterium is toxic for head and neck squamous cell carcinoma and its presence may determine a better prognosis
Anjali Chander, Jacopo Iacovacci, Aize Pellon, Rhadika Kataria, Anita Grigoriadis, John Maher, Cynthia Sears, Gilad Bachrach, Teresa Guerrero Urbano, Mary Lei, Imran Petkar, Anthony Kong, Tony Ng, Ester Orlandi, Nicola Alessandro Iacovelli, Loris De Cecco
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 7/6/2024 doi:10.1002/cac2.12588
ORIGINAL ARTICLE
Leptin-mediated suppression of lipoprotein lipase cleavage enhances lipid uptake and facilitates lymph node metastasis in gastric cancer
Jian Xiao, Shuqing Cao, Jiawei Wang, Pengyu Li, Quan Cheng, Xinyi Zhou, Jiacheng Dong, Yuan Li, Xinyu Zhao, Zekuan Xu, Li Yang
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 7/3/2024 doi:10.1002/cac2.12583
ORIGINAL ARTICLE
Disitamab vedotin, a HER2-directed antibody-drug conjugate, in patients with HER2-overexpression and HER2-low advanced breast cancer: a phase I/Ib study
Jiayu Wang, Yunjiang Liu, Qingyuan Zhang, Wei Li, Jifeng Feng, Xiaojia Wang, Jianmin Fang, Yiqun Han, Binghe Xu
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 6/28/2024 doi:10.1002/cac2.12577
REVIEW
Find Me and Eat Me signals: tools to drive phagocytic processes for modulating antitumor immunity
Lingjun Xiao, Louqian Zhang, Ciliang Guo, Qilei Xin, Xiaosong Gu, Chunping Jiang, Junhua Wu
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 6/23/2024 doi:10.1002/cac2.12579
RESEARCH HIGHLIGHTS
Interleukin-10 gives exhausted chimeric antigen receptor (CAR) T cells a second breath
Christoph Heuser-Loy
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 6/11/2024 doi:10.1002/cac2.12575
REVIEW
The regulatory roles and clinical significance of glycolysis in tumor
Qiqi Qiao, Shunfeng Hu, Xin Wang
Cancer Communications 2024 44: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 6/8/2024 doi:10.1002/cac2.12549
